Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barcos

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of Cancer and Leukemia Group B Study 7851S J Ginsberg, J R Anderson, A J Gottlieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group BS M Lichtman, D Niedzwiecki, M Barcos, et al.
American Journal of Hematology|February 1, 1993
Clinical and prognostic significance of in vivo differentiation in acute myeloid leukemiaA Raza, H Preisler, B Lampkin, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: relationship to response to remission induction therapyH D Preisler, A Raza, N Azarnia, et al.
Leukemia Research|January 1, 1991
Cell cycle and clinical characteristics of patients with acute myeloid leukemia and myelodysplasia whose biopsies are reactive with anti-factor VIII antibody. A Leukemia Intergroup StudyS P Khan, A Raza, M Barcos, et al.
The American Journal of Medicine|August 1, 1984
Staging laparotomy and splenectomy in early Hodgkin's disease. No therapeutic benefitG A Gomez, P A Reese, H Nava, et al.
Leukemia & Lymphoma|November 9, 2001
Acute myeloid leukemia in the setting of low dose weekly methotrexate therapy for rheumatoid arthritisB Kolte, A N Baer, S N Sait, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup StudyH D Preisler, A Raza, M Barcos, et al.
American Journal of Hematology|October 1, 1986
High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup studyH D Preisler, A Raza, M Barcos, et al.
Cancer Research|February 15, 1997
Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assayM Yoshida, R J Rybak, Y Choi, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of Cancer and Leukemia Group B Study 7851S J Ginsberg, J R Anderson, A J Gottlieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group BS M Lichtman, D Niedzwiecki, M Barcos, et al.
American Journal of Hematology|February 1, 1993
Clinical and prognostic significance of in vivo differentiation in acute myeloid leukemiaA Raza, H Preisler, B Lampkin, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: relationship to response to remission induction therapyH D Preisler, A Raza, N Azarnia, et al.
Leukemia Research|January 1, 1991
Cell cycle and clinical characteristics of patients with acute myeloid leukemia and myelodysplasia whose biopsies are reactive with anti-factor VIII antibody. A Leukemia Intergroup StudyS P Khan, A Raza, M Barcos, et al.
The American Journal of Medicine|August 1, 1984
Staging laparotomy and splenectomy in early Hodgkin's disease. No therapeutic benefitG A Gomez, P A Reese, H Nava, et al.
Leukemia & Lymphoma|November 9, 2001
Acute myeloid leukemia in the setting of low dose weekly methotrexate therapy for rheumatoid arthritisB Kolte, A N Baer, S N Sait, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup StudyH D Preisler, A Raza, M Barcos, et al.
American Journal of Hematology|October 1, 1986
High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup studyH D Preisler, A Raza, M Barcos, et al.
Cancer Research|February 15, 1997
Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assayM Yoshida, R J Rybak, Y Choi, et al.
Pageof 10